Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel, Placebo-controlled, Double-blind Phase IIa Study of Efficacy and Safety of Recombinant Human Neuregulin-1 (Neucardin) in Subjects With Stable Chronic Heart Failure

NCT01251406 is registered in ClinicalTrials.gov with Zensun Sci. & Tech. Co., Ltd. as lead sponsor.

NCT NCT01251406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01251406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel, Placebo-controlled, Double-blind Phase IIa Study of Efficacy and Safety of Recombinant Human Neuregulin-1 (Neucardin) in Subjects With Stable Chronic Heart Failure
Lead sponsor
Zensun Sci. & Tech. Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
March 31, 2014
Enrollment
67 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure